Form 4 for LH Labcorp
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0001127602-24-003958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-08 | 2024-02-07 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $223.71 | -204 | 21.1K | -1.0% | -$45.6K |
| DM | 2024-02-08 | 2024-02-07 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +629 | 21.1K | +3% | — |
| DM | 2024-02-08 | 2024-02-07 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | $0.00 | -629 | 15.9K | -4% | $0 |
| DM | 2024-02-08 | 2024-02-06 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | A - Grant | $0.00 | +8,210 | 16.4K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | F | D | 171 | $223.71 | 20,972.04 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-07 | F | D | 33 | $223.71 | 21,051.04 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-07 | M | A | 517 | — | 21,143.04 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 4 | Common | Common Stock | 2024-02-07 | M | A | 112 | — | 21,084.04 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 5 | Derivative | Restricted Stock Unit | 2024-02-07 | M | D | 112 | $0.00 | 15,768 | D | — · — to — | 112 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F7) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. |
| 6 | Derivative | Restricted Stock Unit | 2024-02-07 | M | D | 517 | $0.00 | 15,880 | D | — · — to — | 517 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F7) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. |
| 7 | Derivative | Non-qualified Stock Options | 2024-02-06 | A | A | 6,200 | $0.00 | 6,200 | D | $222.28 · 2025-02-06 to 2034-02-05 | 6,200 Common Stock | (F5) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F6) The option vests in three equal annual installments beginning on the date reflected in this column. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-06 | A | A | 2,010 | $0.00 | 16,397 | D | — · — to — | 2,010 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025. |